Breast Cancer Clinical Trial

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

Summary

This study is designed to collect data about the amount of time required to use the assay in clinical-use conditions.

View Full Description

Full Description

Assay turn-around-time will be collected at sites that are using the GeneSearch BLN Assay for intraoperative testing of sentinel lymph nodes. The sites must be planning to use the assay result to guide the decision to complete an axillary lymph node dissection.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Pre-operatively established diagnosis of invasive carcinoma of the breast
Scheduled for axillary sentinel lymph node dissection as per standard of care at the clinical site for newly diagnosed breast cancer patients
Patients for whom the GeneSearchâ„¢ BLN Assay will be used intra-operatively to make a decision for an axillary lymph node dissection
18 years of age or older
Female or male

Exclusion Criteria:

Previous diagnosis of lymphoma
Subjects participating in other research studies that would interfere with their full participation in this study
Patients and/or conditions with 'interfering substances' as listed in the IFU
Patients who have had any pre-operative treatment for breast cancer including neoadjuvant and/or hormonal intervention such as aromatase inhibitors or tamoxifen

Study is for people with:

Breast Cancer

Estimated Enrollment:

233

Study ID:

NCT00595023

Recruitment Status:

Terminated

Sponsor:

Janssen Diagnostics, LLC

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 6 Locations for this study

See Locations Near You

Cedars-Sinai Medical Center
Los Angeles California, 90048, United States
Georgetown University Medical Center
Washington District of Columbia, 20007, United States
Morton Plant Hospital
Clearwater Florida, 33756, United States
St. Anthony's Hospital
St. Petersburg Florida, 33705, United States
Georgia Esoteric and Molecular Labs, LLC
Augusta Georgia, 30912, United States
Woman's Hospital
Flowood Mississippi, 39232, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

233

Study ID:

NCT00595023

Recruitment Status:

Terminated

Sponsor:


Janssen Diagnostics, LLC

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider